These antihypertensive drugs have been described to increase the expression of the ACE2 enzyme, the SARS-CoV2 cell entry receptor, and for this reason it was speculated during the early stages of the COVID-19 pandemic that this class of drugs might facilitate infection. Here, ACE2 is linked to COVID-19.